超声造影结合AFP、SAA/CRP水平在肝细胞腺瘤及肝细胞癌鉴别诊断中的应用

肝脏 ›› 2025, Vol. 30 ›› Issue (2): 211-215.

超声造影结合AFP、SAA/CRP水平在肝细胞腺瘤及肝细胞癌鉴别诊断中的应用

王倩, 梁爽, 李静, 徐佳琪, 王方旭

066000 河北北京中医药大学东方医院秦皇岛医院(秦皇岛市中医医院)超声科(王倩,梁爽,李静,徐佳琪), 放射科(王方旭)

收稿日期:2024-01-09 出版日期:2025-02-28 发布日期:2025-03-17
通讯作者: 王方旭,Email: 18603392234@163.com
基金资助:
河北省自然科学基金(H2021209026)

Application of contrast-enhanced ultrasound combined with serum alpha fetoprotein (AFP) and amyloid A/C-reactive protein (SAA/CRP) levels in the differential diagnosis of hepatocellular adenoma and carcinoma

WANG Qian¹, LIANG Shuang¹, LI Jing¹, XU Jia-qi¹, WANG Fang-xu²

1. Department of Ultrasound, Beijing University of Traditional Chinese Medicine Dongfang Hospital Qinhuangdao Hospital (Qinhuangdao Traditional Chinese Medicine Hospital), Hebei 066000, China;
2. Department of Radiology , Beijing University of Traditional Chinese Medicine Dongfang Hospital Qinhuangdao Hospital (Qinhuangdao Traditional Chinese Medicine Hospital), Hebei 066000, China

Received:2024-01-09 Online:2025-02-28 Published:2025-03-17
Contact: WANG Fang-xu,Email: 18603392234@163.com

摘要/Abstract

摘要： 目的评估超声造影(contrast-enhanced ultrasound, CEUS)结合血清甲胎蛋白(alpha-fetoprotein, AFP)、血清淀粉样蛋白A/C反应蛋白(serum amyloid A/C-reactive protein, SAA/CRP)水平在肝细胞腺瘤(hepatocellular adenoma, HCA)与肝细胞癌(hepatocellular carcinoma, HCC)鉴别诊断中的价值。方法回顾性分析2020年3月—2023年6月于秦皇岛市中医医院治疗的119例患者,其中60例为HCC患者(高分化28例,低分化32例),29例为HCA患者,其中肝细胞核因子1α(HNF1α)失活型(H-HCA)患者10例,β-catenin活化型(β-HCA)患者10例,炎性HCA(I-HCA) 患者9例。所有患者均接受了CEUS检查,比较各组患者CEUS参数(始增时间、始增强度、达峰时间及达峰强度),通过酶联免疫吸附试验(enzyme-linked immunosorbent assay, ELISA)测定患者血清AFP、SAA、CRP水平,并构建受试者操作特征(receiver operating characteristic, ROC)曲线、进行COX多因素分析评估超声造影结合AFP、SAA/CRP水平在HCA及HCC中的诊断价值。结果 CEUS参数(始增时间、达峰时间及达峰强度)在HCC患者中均低于HCA患者(P<0.05),SAA/CRP水平能够区分HCA与HCC;特别是在HCC患者中,生物标志物水平能反映疾病分化程度,显示出高敏感度和特异度;超声造影结合AFP、SAA/CRP水平的联合诊断在HCA及HCC的检测中表现出最高的诊断效能,其AUC值为0.953,灵敏度为93.1%,特异度为90.0%,约登指数为0.831,高于单独诊断方法;行多因素 COX 分析显示,始增时间、始增强度、达峰时间及达峰强度、AFP和SAA/CRP水平均为影响HCA及HCC诊断的因素(P<0.05)。结论 CEUS结合血清AFP、SAA/CRP水平的检测为HCA与HCC的鉴别诊断提供了一种高度准确的方法。这种联合检测方法的高敏感度和特异度可能对临床决策和患者的治疗方案选择有重要影响。

关键词: 超声造影, 血清甲胎蛋白, 血清淀粉样蛋白A/C反应蛋白, 肝细胞腺瘤, 肝细胞癌, 诊断价值

Abstract: Objective To evaluate the effectiveness of contrast-enhanced ultrasound (CEUS) combined with serum alpha fetoprotein (AFP) and serum amyloid A/C-reactive protein (SAA/CRP) levels in distinguishing between hepatocellular adenoma (HCA) and hepatocellular carcinoma (HCC). Methods A retrospective analysis was conducted on 119 patients treated in Qinhuangdao Traditional Chinese Medicine Hospital from March 2020 to June 2023. Among them, 60 were HCC patients,(28 with high differentiation and 32 with low differentiation), and 29 were HCA patients. Among them, 10 were HNF1a mutant (H-HCA) patients, 10 were β- Catenin mutant with HCA, and 9 were inflammatory HCA type (IHCA). We compared the CEUS parameters (starting time, starting intensity, peak time, and peak intensity) of all patients underwent CEUS examination. Serum AFP, SAA, and CRP levels were measured using enzyme-linked immunosorbent assay (ELISA). The receiver operating characteristic (ROC) curves and COX multivariate analysis were performed to evaluate the combination of CEUS, AFP, and SAA/CRP levels in diagnosing HCA and HCC. Results CEUS parameters (onset time, peak time, and peak intensity) in HCC group were lower than that in HCA group (P<0.05), and SAA/CRP levels could distinguish between HCA and HCC; The level of biomarkers can reflect the differentiation degree of HCC, showing high sensitivity and specificity; The combination of CEUS with AFP and SAA/CRP levels showed the highest diagnostic efficacy in the detection of HCA and HCC, with an area under the curve of 0.953, sensitivity of 93.1%, specificity of 90.0%, and a Yoden index of 0.831, which achieved better diagnostic efficacy than using a single indicator; Multivariate COX analysis showed that the onset time, onset intensity, peak time and intensity, AFP and SAA/CRP levels were all factors affecting the diagnosis of HCA and HCC (P<0.05). Conclusion CEUS combined with the serum AFP and SAA/CRP provides a higher accurate method for the differential diagnosis of HCA and HCC. The high sensitivity and specificity of this combination method may have a significant impact on clinical decision-making and patient treatment choice.

Key words: Contrast-enhanced ultrasound, Serum alpha fetoprotein, Serum amyloid A/C reactive protein, Liver adenoma, Hepatocellular carcinoma, Diagnostic value

王倩, 梁爽, 李静, 徐佳琪, 王方旭. 超声造影结合AFP、SAA/CRP水平在肝细胞腺瘤及肝细胞癌鉴别诊断中的应用[J]. 肝脏, 2025, 30(2): 211-215.

WANG Qian, LIANG Shuang, LI Jing, XU Jia-qi, WANG Fang-xu. Application of contrast-enhanced ultrasound combined with serum alpha fetoprotein (AFP) and amyloid A/C-reactive protein (SAA/CRP) levels in the differential diagnosis of hepatocellular adenoma and carcinoma[J]. Chinese Hepatolgy, 2025, 30(2): 211-215.

/ 推荐

参考文献

[1] Federica L, Antonio S D, Giovanni M. A case of symptomatic intramesenteric accessory spleen: The diagnostic role of contrast-enhanced ultrasound[J]. Ultrasound,2023,31(4):312-316.
[2] BiLi L, Yue S, Qi Z, et al. Value of contrast-enhanced percutaneous ultrasound in the diagnosis of rotator cuff tear subtype[J]. Zhongguo gu shang,2023,36(10):974-981.
[3] Xia T, Lei X, Qingshu L, et al. Molecular evolution in different subtypes of multifocal hepatocellular carcinoma.[J]. Hepatol Int,2023,17(6):1429-1443.
[4] 娄可心, 付尧, 吴鸿雁, 等. 肝脏转移性消化道肝样腺癌:一种易与原发性肝细胞肝癌混淆的高级别癌[J]. 中华病理学杂志,2020,49(7):710-714.
[5] KunLi Y, Ming L, Rui L, et al.The combination of a prolonged treatment time window and alpha-fetoprotein benefits the tumor response of hepatocellular carcinoma patients as evaluated by the imRECIST: a single-center, retrospective study[J]. J Gastrointest Oncol,2023,14(2):932-942.
[6] 郑小美, 王婷, 段化伟, 等. 单次柴油机尾气颗粒物暴露致小鼠急性损伤研究[J]. 环境卫生学杂志,2020,10(5):435-441,封3-封4.
[7] Myers L, Ahn J. Focal Nodular Hyperplasia and Hepatic Adenoma[J]. Clin Liver Dis,2020,24(3):389-403.
[8] Kis E L, Centeno A B, Anaya A D, et al. Hepatic adenoma rupture following portal vein embolization[J]. Radiol Case Rep,2020,15(6):664-667.
[9] Abu F B, Abdel-Rauf Z, Abu S M, et al. Benign Hepatic Tumors: From Incidental Imaging Finding to Clinical Management[J]. Korean J Fam Med,2020,42(1):2-8.
[10] ChongKe Z, Xin G, YinYing P, et al. Response Evaluation Using Contrast-Enhanced Ultrasound for Unresectable Advanced Hepatocellular Carcinoma Treated With Tyrosine Kinase Inhibitors Plus Anti-PD-1 Antibody Therapy[J]. Ultrasound Med Biol,2023,50(1):142-149.
[11] Jia X, Shu A, Ying L, et al.Preoperative alpha fetoprotein, total bilirubin, fibrinogen, albumin, and lymphocytes predict postoperative survival in hepatocellular carcinoma[J]. Cancer Med,2023,12(12):13319-13328.
[12] 熊飞翔, 孟培培, 江宇泳, 等. C反应蛋白与白蛋白比值对酒精性肝硬化合并自发性细菌性腹膜炎的诊断价值[J]. 临床肝胆病杂志,2023,39(8):1880-1885.
[13] 张瑞, 郑军, 杨浩, 等. 个体化肠外营养支持对比预混肠外营养配方对急性肾损伤患者肝功能的影响[J]. 中国药房,2023,34(4):457-460.
[14] 李小娟, 黄品同, 徐永远, 等. 超声造影肝影像报告和数据系统与磁共振肝影像报告和数据系统对肝细胞癌高危患者肝占位性病变的一致性评价研究[J]. 中华超声影像学杂志,2020,29(6):522-528.
[15] 严成, 陈新国, 金海龙, 等. 基于术前血清学指标AFP和GGT的标准在预测肝细胞癌患者肝移植术后长期生存中的作用研究[J]. 器官移植,2023,14(2):248-256.
[16] 王鹏雁, 邵汇琳, 班新超, 等. 基于免疫组化的肝细胞腺瘤分型及临床病理学分析[J]. 中华肝胆外科杂志,2019,25(7):509-512.
[17] 韩云霞, 李雪梅, 欧阳向柳, 等. 超声造影结合定量分析法及血清TSH、Gal-3、CK-19诊断甲状腺微小乳头状癌的临床价值[J]. 中国现代医学杂志,2023,33(16):84-91.
[18] 陈凡, 陈春, 刘颖, 等. 超声造影参数联合声触诊组织量化技术对肝细胞癌及肝血管瘤的鉴别诊断价值[J]. 中国医学装备,2022,19(10):79-82.
[19] 张庆玉, 吴鹏波, 谭诗云. AFTP、CRP、SAA在腹腔积液鉴别诊断中的价值[J]. 医学研究杂志,2023,52(3):133-136,65.
[20] 杨跃青, 张燕, 寇少杰, 等. 非酒精性脂肪性肝病严重程度与氧化应激、SAA、CRP和脑动脉硬化的相关性研究[J]. 中西医结合肝病杂志,2022,32(6):520-524.
[21] 卢燕辉, 卢秋燕, 颜治云, 等. 乙型肝炎相关肝癌在唾液中生物学标志物的研究与探索[J]. 中华肝脏病杂志,2023,31(5):495-503.